FDA — authorised 8 December 1950
- Marketing authorisation holder: PARKEDALE
- Status: approved
🇺🇸 Chlorocidin in United States
FDA authorised Chlorocidin on 8 December 1950
Marketing authorisations
FDA — authorised 9 December 1953
- Application: NDA050202
- Marketing authorisation holder: PARKEDALE
- Local brand name: CHLOROMYCETIN HYDROCORTISONE
- Indication: FOR SUSPENSION — OPHTHALMIC
- Status: approved
FDA — authorised 25 June 1958
- Application: NDA050201
- Marketing authorisation holder: PARKEDALE
- Local brand name: OPHTHOCORT
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA — authorised 1 April 1964
- Application: BLA050294
- Marketing authorisation holder: PARKE DAVIS
- Local brand name: ELASE-CHLOROMYCETIN
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 20 June 1967
- Application: ANDA060851
- Marketing authorisation holder: ARMENPHARM
- Local brand name: MYCHEL
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 20 March 1968
- Application: NDA050091
- Marketing authorisation holder: ALLERGAN
- Local brand name: CHLOROPTIC
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 1 October 1968
- Application: ANDA060133
- Marketing authorisation holder: ALTANA
- Local brand name: CHLORAMPHENICOL
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA — authorised 21 July 1970
- Application: ANDA061187
- Marketing authorisation holder: ALLERGAN
- Local brand name: CHLOROPTIC S.O.P.
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA — authorised 18 November 1970
- Application: ANDA061220
- Marketing authorisation holder: PARKEDALE
- Local brand name: OPHTHOCHLOR
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 26 April 1973
- Application: ANDA061645
- Marketing authorisation holder: ALCON
- Local brand name: ECONOCHLOR
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 14 May 1974
- Application: ANDA061648
- Marketing authorisation holder: ALCON
- Local brand name: ECONOCHLOR
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA — authorised 28 April 1980
- Application: ANDA062247
- Marketing authorisation holder: IVAX SUB TEVA PHARMS
- Local brand name: CHLORAMPHENICOL
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 31 August 1981
- Application: ANDA062042
- Marketing authorisation holder: EPIC PHARMA LLC
- Local brand name: CHLORAMPHENICOL
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 31 March 1982
- Application: ANDA062171
- Marketing authorisation holder: OPTOPICS
- Local brand name: OPTOMYCIN
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 25 September 1985
- Application: ANDA062628
- Marketing authorisation holder: ALCON
- Local brand name: CHLORAMPHENICOL
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 23 November 1988
- Application: ANDA062365
- Marketing authorisation holder: FRESENIUS KABI USA
- Indication: Manufacturing (CMC)
- Status: approved
FDA
- Application: NDA050203
- Marketing authorisation holder: PARKE DAVIS
- Local brand name: CHLOROMYXIN
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Application: ANDA061188
- Marketing authorisation holder: ALLERGAN
- Local brand name: CHLOROPTIC-P S.O.P.
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Application: ANDA062406
- Marketing authorisation holder: ELKINS SINN
- Local brand name: CHLORAMPHENICOL
- Indication: INJECTABLE — INJECTION
- Status: approved
Chlorocidin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Chlorocidin approved in United States?
Yes. FDA authorised it on 8 December 1950; FDA authorised it on 9 December 1953; FDA authorised it on 25 June 1958.
Who is the marketing authorisation holder for Chlorocidin in United States?
PARKEDALE holds the US marketing authorisation.